IMS Health Holdings, Inc.

IMS Health Holdings, Inc.

IMS

IMSIMS Health Holdings, Inc. US flag

New York Stock Exchange

31.34

USD

+0.84

- -

CIK

0001595262

Return %

Stock

S&P500

1Y

- -

26.53

3Y

- -

76.60

5Y

- -

80.11

Use logarithmic scale

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Company Description

Sector: Healthcare
Industry: Medical - Healthcare Information Services
Address
IPO Date: Apr 3, 2014
CIK: 0001595262
Similar Companies: Mangoceuticals, Inc. (MGRX)
CSAM Health Group AS (CSAMF)
BioRegenx, Inc. (BRGX)
Bullfrog AI Holdings, Inc. Common Stock (BFRG)
1st Group Limited (1ST.AX)
Kusurinomadoguchi, Inc. (5592.T)
Business: IMS Health Holdings, Inc. operates as a global information and technology services company serving the healthcare industry. The company offers comprehensive data and analytics services including pharmaceutical and medical device market intelligence, patient-level data, physician prescribing data, clinical trial analytics, technology and consulting services. Its core products encompass healthcare data integration and analytics platforms, cloud-based software solutions like IMS One for business analytics, commercial operations support, sales force effectiveness tools, multi-channel marketing, lifecycle management, and payer-provider contracting and performance management solutions. IMS Health primarily serves pharmaceutical, biotechnology, consumer health manufacturers, distributors, providers, payers, government agencies, and researchers across the United States and international markets. IMS Health was founded in 1954 and is headquartered in Danbury, Connecticut. The company has expanded through acquisitions such as SDI Health in the U.S. and Ardentia Ltd in the U.K., enhancing its specialty and patient-level data capabilities. In 2016, IMS Health merged with Quintiles Transnational Holdings Inc., creating QuintilesIMS (now IQVIA), combining healthcare information with contract research and technology services to address the full life sciences product lifecycle from R&D through commercial execution to patient outcomes. Recent changes include the integration and operational consolidation of services under the IQVIA brand, enhancing technology service offerings including cloud infrastructure and analytics, with a focus on driving efficiencies across global healthcare operations. IMS Health’s solutions leverage extensive global healthcare datasets exceeding 10 petabytes, connecting disease, treatment, cost, and outcome data via proprietary analytics hosted on its intelligent cloud platform. The company’s ongoing strategic expansion targets broader healthcare industry needs, including clinical trial design and execution tools, payer services optimization, and real-world evidence generation. This positions IMS Health as a critical partner in healthcare decision-making processes worldwide, leveraging technology and data to improve healthcare performance and outcomes. The company operates in over 100 countries and maintains dual headquarters in Danbury, Connecticut, and Research Triangle Park, North Carolina. Its recent strategic focus emphasizes enhancing commercial, operational, and financial synergies through technology integration and expanding its market reach in emerging and developed healthcare markets globally. IMS Health Holdings, Inc. is recognized as a leading provider of healthcare information, technology, and services, innovating in areas such as data analytics, cloud solutions, and life sciences research support to serve a wide range of healthcare stakeholders, including life sciences companies, healthcare providers, payers, and governments. The company’s evolution through mergers, acquisitions, and technology upgrades reflects its commitment to advancing healthcare delivery and decision-making.

Company News